: A Review of Its Antitumor Effects on Non-Small Cell Lung Cancer

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2024 Jul 31

PMID 39081698

Authors

Zhenyu Li

Jimin Liu

Haishan Cui

Wenlong Qi

Yangyang Tong

Tan Wang

Affiliations

Soon will be listed here.

Abstract

The rising global morbidity and mortality rates of non-small cell lung cancer (NSCLC) underscore the urgent need for more effective treatments. Current therapeutic modalities-including surgery, radiotherapy, chemotherapy, and targeted therapy-face several limitations. Recently, , a traditional Chinese medicine (TCM), has captured significant attention due to its broad pharmacological properties, such as immune regulation, anti-inflammatory effects, and the modulation of reactive oxygen species (ROS) and enzyme activities. This review delivers a comprehensive summary of the most recent advancements and ongoing applications of in NSCLC treatment, underlining its potential for integration into existing treatment protocols. It also highlights essential areas for future research, including the elucidation of its molecular mechanisms, optimization of dosage and administration, and evaluation of its efficacy and safety alongside standard therapies, all of which could potentially improve therapeutic outcomes for NSCLC patients.

Citing Articles

Complete Response of Locally Advanced Lung Adenocarcinoma Following Basil Combined With Cisplatin Plus Pemetrexed Chemotherapy: A Case Report.

He C, Li L, Feng B, Xie L, Zhang L, Liu B Integr Cancer Ther. 2024; 23:15347354241295269.

PMID: 39511726 PMC: 11544759. DOI: 10.1177/15347354241295269.

References

Skowron M, Oing C, Bremmer F, Strobel P, Murray M, Coleman N . The developmental origin of cancers defines basic principles of cisplatin resistance. Cancer Lett. 2021; 519:199-210. DOI: 10.1016/j.canlet.2021.07.037. View

Uchida M, Yamaguchi Y, Hosomi S, Ikesue H, Mori Y, Maegawa N . Risk Factors for Febrile Neutropenia Induced by Docetaxel Chemotherapy in Patients with Non-small Cell Lung Cancer. Biol Pharm Bull. 2020; 43(8):1235-1240. DOI: 10.1248/bpb.b20-00266. View

Castegna A, Gissi R, Menga A, Montopoli M, Favia M, Viola A . Pharmacological targets of metabolism in disease: Opportunities from macrophages. Pharmacol Ther. 2020; 210:107521. DOI: 10.1016/j.pharmthera.2020.107521. View

He L, Xu K, Niu L, Lin L . polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCC. Pharm Biol. 2022; 60(1):1710-1720. PMC: 9467620. DOI: 10.1080/13880209.2022.2112963. View

Meng X, Wei M, Wang D, Qu X, Zhang K, Zhang N . polysaccharides protect renal function and affect the TGF-/Smad signaling pathway in streptozotocin-induced diabetic rats. J Int Med Res. 2020; 48(5):300060520903612. PMC: 7263164. DOI: 10.1177/0300060520903612. View

Ming K, Zhuang S, Ma N, Nan S, Li Q, Ding M . polysaccharides alleviates lipopolysaccharides-induced inflammatory lung injury by altering intestinal microbiota in mice. Front Microbiol. 2022; 13:1033875. PMC: 9640976. DOI: 10.3389/fmicb.2022.1033875. View

Han R, Tang F, Lu M, Xu C, Hu J, Mei M . Protective effects of Astragalus polysaccharides against endothelial dysfunction in hypertrophic rats induced by isoproterenol. Int Immunopharmacol. 2016; 38:306-12. DOI: 10.1016/j.intimp.2016.06.014. View

Gao Z, Liu K, Tian W, Wang H, Liu Z, Li Y . Effects of selenizing angelica polysaccharide and selenizing garlic polysaccharide on immune function of murine peritoneal macrophage. Int Immunopharmacol. 2015; 27(1):104-9. DOI: 10.1016/j.intimp.2015.04.052. View

Phacharapiyangkul N, Wu L, Lee W, Kuo Y, Wu Y, Liou H . The extracts of enhance chemosensitivity and reduce tumor indoleamine 2, 3-dioxygenase expression. Int J Med Sci. 2019; 16(8):1107-1115. PMC: 6743273. DOI: 10.7150/ijms.33106. View

10.

Tao X, Zhang X, Feng F . Astragalus Polysaccharide Suppresses Cell Proliferation and Invasion by Up-Regulation of miR-195-5p in Non-small Cell Lung Cancer. Biol Pharm Bull. 2022; 45(5):553-560. DOI: 10.1248/bpb.b21-00634. View

11.

Du Y, Zheng Y, Yu C, Zhong L, Li Y, Wu B . The Mechanisms of Yu Ping Feng San in Tracking the Cisplatin-Resistance by Regulating ATP-Binding Cassette Transporter and Glutathione S-Transferase in Lung Cancer Cells. Front Pharmacol. 2021; 12:678126. PMC: 8202081. DOI: 10.3389/fphar.2021.678126. View

12.

Hu P, Suriguga , Zhao M, Chen S, Wu X, Wan Q . Transcriptional regulation mechanism of flavonoids biosynthesis gene during fruit development in . Front Genet. 2022; 13:972990. PMC: 9485568. DOI: 10.3389/fgene.2022.972990. View

13.

Bamodu O, Kuo K, Wang C, Huang W, Wu A, Tsai J . (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer. Nutrients. 2019; 11(10). PMC: 6836209. DOI: 10.3390/nu11102264. View

14.

Liu D, Su J, Lin J, Qian G, Chen X, Song S . Activation of AMPK-dependent SIRT-1 by astragalus polysaccharide protects against ochratoxin A-induced immune stress in vitro and in vivo. Int J Biol Macromol. 2018; 120(Pt A):683-692. DOI: 10.1016/j.ijbiomac.2018.08.156. View

15.

Guo X, Yin T, Chen D, Xu S, Ye R, Zhang Y . Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes Modulating MIR-21/PTEN/PI3K/AKT Signaling. Endocr Metab Immune Disord Drug Targets. 2023; 23(12):1538-1547. DOI: 10.2174/1871530323666230627121700. View

16.

Du Y, Wan H, Huang P, Yang J, He Y . A critical review of Astragalus polysaccharides: From therapeutic mechanisms to pharmaceutics. Biomed Pharmacother. 2022; 147:112654. DOI: 10.1016/j.biopha.2022.112654. View

17.

Zhou Y, Hong T, Tong L, Liu W, Yang X, Luo J . Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway. Int J Mol Med. 2018; 42(6):3093-3104. PMC: 6202104. DOI: 10.3892/ijmm.2018.3868. View

18.

Liu P, Zhao H, Luo Y . Anti-Aging Implications of (Huangqi): A Well-Known Chinese Tonic. Aging Dis. 2018; 8(6):868-886. PMC: 5758356. DOI: 10.14336/AD.2017.0816. View

19.

Liang Y, Chen B, Liang D, Quan X, Gu R, Meng Z . Pharmacological Effects of Astragaloside IV: A Review. Molecules. 2023; 28(16). PMC: 10458270. DOI: 10.3390/molecules28166118. View

20.

Sheik A, Kim K, Varaprasad G, Lee H, Kim S, Kim E . The anti-cancerous activity of adaptogenic herb Astragalus membranaceus. Phytomedicine. 2021; 91:153698. DOI: 10.1016/j.phymed.2021.153698. View